Cordyceps,
does it really help with Vitality, immunity, and exercise?
research showsCordyceps is not an ingredient with no human research at all. However, positive immune results are mainly surrogate markers such as NK cell activity and IgA, and actual upper respiratory infection incidence did not decrease versus placebo. Exercise and vitality also have small RCTs, but single Cordyceps, Cs-4, C. militaris, mushroom mixtures, and Rhodiola combinations are mixed, so the general claim that "Cordyceps increases vitality and exercise capacity" remains weak.
ads claimKorean market advertisements and informational articles tend to broaden claims to "immune enhancement," "immune-cell activation," "high cordycepin content," "natural antibiotic," "fatigue recovery/vitality," "endurance/exercise-performance improvement," "tonic/strengthening," and even "anticancer/cardiovascular prevention." Coupang product names directly foregrounded "cordycepin immune-function enhancement," and a Dong-A Pharmaceutical press release emphasized a product that "helps enhance immunity" and activation of immune cells in human testing. Policy/agriculture promotional articles also introduced MFDS recognition and animal/human immune indicators while using traditional efficacy phrases such as fatigue recovery and anti-aging.
Useful facts when choosing a product
- In Korea, "Cordyceps alcohol extract" is mentioned as an individually recognized ingredient related to immune function. Regulatory recognition and this evidence grade were judged separately.
- Advertising often bundles different materials under the single name "Cordyceps," including C. militaris alcohol extract, C. sinensis fermented mycelium (Cs-4), Paecilomyces hepiali CBG-CS-2, and mushroom mixtures containing C. militaris.
- Many products emphasize cordycepin content, but marker compounds, extraction methods, and doses differ by study, making direct extrapolation to the whole product category difficult.
- PeakO2-type positive exercise studies are not C. militaris alone but combination products containing several mushrooms, so they are difficult to interpret as single-ingredient effects.
- Short-term RCTs did not show many major safety signals, but caution is needed with glucose-lowering drugs, anticoagulant/antiplatelet use, immunosuppressive therapy, autoimmune disease, pregnancy/lactation, and perioperative periods.
What the research actually shows
Immunity: 2 RCTs of C. militaris alcohol extract and a CBG-CS-2 RCT improved NK cell activity, IgA, and some Th1 cytokines, but the evidence is surrogate-marker-centered. A 12-week URI RCT found significant NK cell and IgA changes, but URI occurrence and symptoms were not significant. Exercise/vitality: Cs-4-alone RCTs improved only metabolic/ventilatory thresholds in a small healthy older-adult study while VO2max was unchanged, and a Cs-4-alone RCT in trained cyclists was negative. Mushroom-mixture studies containing C. militaris, such as PeakO2, show some VO2peak and time-to-fatigue improvements, but have combination-product, small-sample, and industry-funding issues. A 2025 fungal supplementation meta-analysis reported small significant Cordyceps-related indicators, but included studies were few and heterogeneous in formulation, population, and funding.
Why this is classified as C (46)
Boundary rule 1 was applied. The positive primary signals for immune claims concentrate on surrogate markers such as NK cell activity, IgA, and cytokines, so the maximum is C. Clinical endpoints such as colds/upper respiratory infections were not significant. Exercise/vitality has human RCTs, but small samples, mixed formulations, combination products, industry funding, and mixed positive/negative results make it difficult to raise to B. No large independent RCT or Cochrane-level review was identified.
Counterpoint. This is not a completely unsupported ingredient. In particular, C. militaris alcohol extract repeatedly increased NK cell activity in Korean healthy-adult RCTs, and some exercise RCTs and meta-analyses also report indicator improvement. However, the current evidence is closer to "can change immune markers" and still leaves a gap from consumer-experienced claims such as "reduces colds," "improves fatigue," or "clearly improves exercise performance."
Rejudgment record. Convergent — NK/IgA surrogate markers are positive, but upper-respiratory-infection reduction failed and exercise effects are inconsistent.
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Kang HJ, Baik HW, Kim SJ et al. 2015 | 79 | Possibly manufacturer/industry related | In 79 healthy men, a 4-week RCT of C. militaris alcohol-treated capsules 1.5 g/day increased NK200, lymphocyte proliferation, IL-2, and IFN-gamma versus placebo. | Core | ||
| Jung SJ, Hwang JH, Oh MR, Chae SW 2019 | Double-blind RCT | 94 | Possibly manufacturer/industry related | Immune | In 100 enrolled and 94 analyzed healthy adults, C. militaris alcohol extract 1.5 g/day for 12 weeks increased NK cell activity and IgA, but URI occurrence and symptoms did not differ from placebo. | Core |
| Jung SJ, Jung ES, Choi EK et al. 2019 | Double-blind RCT | 79 | Possibly manufacturer/industry related | In a 79-person healthy-adult RCT, CBG-CS-2 1.68 g/day for 8 weeks reportedly improved NK cell cytotoxic activity by 38.8 ± 17.6% versus placebo (p<0.019). | Core | |
| Ontawong A, Pengnet S, Thim-Uam A et al. 2024 | RCT | Immune | In a small RCT of healthy adults, C. militaris fermented beverage (cordycepin about 2.85 mg/day) for 8 weeks changed some immune-cell and cytokine markers. | Supporting | ||
| Chen S, Li Z, Krochmal R, Abrazado M, Kim W, Cooper CB 2010 | Double-blind | 15 | In 20 enrolled and 15 completing healthy older adults, Cs-4 about 3 g/day for 12 weeks increased metabolic threshold (+10.5%, p=0.022) and ventilatory threshold (+8.5%, p=0.031), but VO2max did not change. | Supporting | ||
| Parcell AC, Smith JM, Schulthies SS, Myrer JW, Fellingham G 2004 | 22 | Possibly manufacturer/industry related | In 22 trained male cyclists, CordyMax Cs-4 3.15 g/day for 5 weeks did not improve VO2peak, ventilatory threshold, or time-trial performance. | Supporting | ||
| Earnest CP, Morss GM, Wyatt F et al. 2004 | 17 | In 17 competitive cyclists, a 14-day RCT of a combination containing Cordyceps sinensis CS-4 1000 mg and Rhodiola 300 mg found no significant peak VO2, time to exhaustion, or peak power. | Supporting | |||
| Hirsch KR, Smith-Ryan AE, Roelofs EJ, Trexler ET, Mock MG 2017 | 10 | Possibly manufacturer/industry related | Gastrointestinal | In a 28-person active-adult RCT, a mushroom mixture containing C. militaris 4 g/day had no major interaction at 1 week and reported some VO2max and TTE improvement after 3 weeks. | Supporting | |
| Dudgeon WD, Thomas DD, Dauch W, Scheett TP, Webster MJ 2018 | Possibly manufacturer/industry related | In a PeakO2 mushroom-mixture study, the 28-day low-dose group improved time to fatigue, VO2peak, and lactate markers, while the 7-day high-dose group had limited changes in fitness-stratified analysis. | Supporting | |||
| Bai Y, Luan C, Wu S et al. 2025 | Meta-analysis | Possibly manufacturer/industry related | A 2025 meta-analysis reported improvements in Cordyceps sinensis-related endurance performance (p=0.05), ventilatory threshold (p=0.03), and VO2peak (p=0.04). | Supporting | ||
| Memorial Sloan Kettering Cancer Center | MSK summarizes mixed exercise-study findings and lists potential interactions with antidiabetic and anticoagulant/antiplatelet drugs and a case of excessive bleeding after dental extraction. | Supporting |
Receipt — 11 References
Every cited source was opened and checked against the live page on 2026-07-07.
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-07 · Corrections: none
Cite this verdict
[Chamgap] Cordyceps × vitality, immunity, and exercise — Evidence Grade C·46. 11 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/energy/cordyceps-vitality/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.